Taiho Pharmaceutical: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== Taiho Pharmaceutical == | |||
[[File:Taiho_HQ.jpg|thumb|right|Headquarters of Taiho Pharmaceutical]] | |||
Taiho Pharmaceutical | '''Taiho Pharmaceutical Co., Ltd.''' is a Japanese pharmaceutical company that specializes in the development, manufacturing, and marketing of pharmaceutical products, particularly in the field of oncology. It is a subsidiary of [[Otsuka Holdings Co., Ltd.]], a major player in the global pharmaceutical industry. | ||
== | == History == | ||
Taiho Pharmaceutical | Taiho Pharmaceutical was established in 1963 and has since grown to become a leader in the field of oncology. The company has focused on the development of innovative cancer treatments and has a strong presence in the Japanese market as well as internationally. | ||
== Research and Development == | == Research and Development == | ||
Taiho Pharmaceutical is | Taiho Pharmaceutical is committed to advancing medical science through its robust [[research and development]] (R&D) efforts. The company invests heavily in R&D to discover and develop new therapies for cancer and other diseases. Taiho's R&D strategy involves both in-house research and collaborations with academic institutions and other pharmaceutical companies. | ||
== Products == | |||
Taiho Pharmaceutical offers a range of products, with a particular emphasis on oncology. Some of its well-known products include: | |||
* '''TS-1''': An oral anticancer agent used in the treatment of gastric cancer and other solid tumors. | |||
* '''Lonsurf''': A combination drug used for the treatment of metastatic colorectal cancer. | |||
* '''Zosyn''': An antibiotic used to treat a variety of bacterial infections. | |||
== | == Global Presence == | ||
Taiho Pharmaceutical has expanded its operations beyond Japan and has established a significant presence in the global market. The company has subsidiaries and affiliates in various countries, including the United States, Europe, and Asia. This global reach allows Taiho to bring its innovative therapies to patients worldwide. | |||
== | == Corporate Philosophy == | ||
Taiho Pharmaceutical is guided by its corporate philosophy, which emphasizes the importance of contributing to the health and well-being of people around the world. The company is dedicated to "delivering hope and happiness to patients and their families" through its innovative products and services. | |||
== | == Related Pages == | ||
* [ | * [[Otsuka Holdings Co., Ltd.]] | ||
* [[Oncology]] | |||
* [[Pharmaceutical industry]] | |||
* [[Cancer treatment]] | |||
[[Category:Pharmaceutical companies of Japan]] | [[Category:Pharmaceutical companies of Japan]] | ||
[[Category: | [[Category:Oncology]] | ||
[[Category: | [[Category:Companies established in 1963]] | ||
Latest revision as of 11:34, 15 February 2025
Taiho Pharmaceutical[edit]
Taiho Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company that specializes in the development, manufacturing, and marketing of pharmaceutical products, particularly in the field of oncology. It is a subsidiary of Otsuka Holdings Co., Ltd., a major player in the global pharmaceutical industry.
History[edit]
Taiho Pharmaceutical was established in 1963 and has since grown to become a leader in the field of oncology. The company has focused on the development of innovative cancer treatments and has a strong presence in the Japanese market as well as internationally.
Research and Development[edit]
Taiho Pharmaceutical is committed to advancing medical science through its robust research and development (R&D) efforts. The company invests heavily in R&D to discover and develop new therapies for cancer and other diseases. Taiho's R&D strategy involves both in-house research and collaborations with academic institutions and other pharmaceutical companies.
Products[edit]
Taiho Pharmaceutical offers a range of products, with a particular emphasis on oncology. Some of its well-known products include:
- TS-1: An oral anticancer agent used in the treatment of gastric cancer and other solid tumors.
- Lonsurf: A combination drug used for the treatment of metastatic colorectal cancer.
- Zosyn: An antibiotic used to treat a variety of bacterial infections.
Global Presence[edit]
Taiho Pharmaceutical has expanded its operations beyond Japan and has established a significant presence in the global market. The company has subsidiaries and affiliates in various countries, including the United States, Europe, and Asia. This global reach allows Taiho to bring its innovative therapies to patients worldwide.
Corporate Philosophy[edit]
Taiho Pharmaceutical is guided by its corporate philosophy, which emphasizes the importance of contributing to the health and well-being of people around the world. The company is dedicated to "delivering hope and happiness to patients and their families" through its innovative products and services.
